Blind Mice Eyesight Treated With Transplanted Cells.

http://www.bbc.co.uk/news/health-17748165?print=true



'Blind' mice eyesight treated with transplanted cells

British scientists have restored the sight of blind mice by transplanting 
light-sensitive photoreceptor cells into their eyes.

The work is a step towards a new treatment for patients with degenerative eye 
diseases.

Scientists at University College London Institute of Ophthalmology injected 
cells from young healthy mice directly into the retinas of adult mice that had
night-blindness.

The findings are published in 
Nature.

The cells transplanted were immature rod-photoreceptor cells, which are 
especially important for seeing in the dark.

After four to six weeks up to one in six of the transplanted cells had formed 
the connections needed to transmit visual information to the brain.

Hidden platform

The researchers tested the vision of the treated mice in a dimly-lit water maze.

Those mice with transplanted rod cells were able to see a visual cue to find a 
hidden platform to enable them to get out of the water. This was in contrast
to untreated mice who found the platform only by chance after lengthy 
exploration of the maze.

Prof Robin Ali, at UCL Institute of Ophthalmology and Moorfields Eye Hospital, 
who led the research said: "We've shown for the first time that transplanted
photoreceptor cells can integrate successfully with the existing retinal 
circuitry and truly improve vision. 

"We're hopeful that we will soon be able to replicate this success with 
photoreceptors derived from embryonic stem cells and eventually to develop human
trials."

Prof Ali said the behavioural maze test was "ultimate proof" that a significant 
amount of vision had been restored in the treated mice.

But although the results appear promising, there are still many steps to go 
before such a treatment might be suitable for patients.

There are two types of photoreceptor in the eye - rods and cones. It has so far 
proved harder to transplant cone photoreceptors - which are crucial for
human sight and tasks like reading.

The scientists also plan to experiment with photoreceptors derived from 
embryonic stem cells. Prof Ali said such cell lines already exist but the 
question
is how efficiently they can transplant them.

Loss of photoreceptors is the cause of blindness in many human eye diseases 
including age-related macular degeneration (AMD), retinitis pigmentosa and 
diabetes-related
blindness.

But many more animal studies will be needed before such a technique would be 
tried with humans.

'Great encouragement'

The research was funded by the Medical Research Council, the Wellcome Trust, 
the Royal Society the British Retinitis Pigmentosa Society, Alcon Research
Institute and The Miller's Trust.

Dr Rob Buckle, head of regenerative medicine at the MRC said: "This is a 
landmark study that will inform future research across a wide range of fields 
including
vision research, neuroscience and regenerative medicine. 

"It provides clear evidence of functional recovery in the damage eye through 
cell transplantation, providing great encouragement for the development of
stem cell therapies to address the many debilitating eye conditions that affect 
millions worldwide."

There are already a number of research programmes aiming to treat blindness 
using cell transplants.

Last year, 
the same research group
 were given the go-ahead to carry out Europe's first clinical trial involving 
human embryonic stem cells at Moorfields Eye Hospital.

That study involves patients with Stargardt's disease, one of the main causes 
of blindness in young people. 
Early results
 suggest the technique is safe but reliable results will take several years.

Fergus Walsh, Medical correspondent Article written by Fergus WalshFergus Walsh
Medical correspondent



Search for old postings at:
http://www.mail-archive.com/accessindia@accessindia.org.in/

To unsubscribe send a message to
accessindia-requ...@accessindia.org.in
with the subject unsubscribe.

To change your subscription to digest mode or make any other changes, please 
visit the list home page at
http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in

Reply via email to